当前位置: X-MOL 学术Bioconjugate Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine
Bioconjugate Chemistry ( IF 4.7 ) Pub Date : 2020-11-30 , DOI: 10.1021/acs.bioconjchem.0c00520
C Tilden Hagan 1, 2, 3 , Yu Mi 1, 2 , Nicole M Knape 1, 2 , Andrew Z Wang 1, 2
Affiliation  

Radiotherapy and immunotherapy are two key treatments for cancer. There is growing evidence that they are also synergistic, and combination treatments are being studied extensively in the clinical setting. In addition, there is emerging evidence that nanotechnology-enabled therapeutics can potentiate both radiotherapy and immunotherapy, in turn improving both treatments. This is an exciting new area of interdisciplinary science and has significant potential for major clinical impact. Some of the approaches in this area have already reached the clinical stage. In this review, we will discuss recent advances in the interface between radiotherapy, immunotherapy, and nanomedicine. We plan to review the many approaches to combine these three fields for cancer treatment.

中文翻译:

通过纳米医学增强联合免疫疗法和放射疗法

放射疗法和免疫疗法是癌症的两种主要治疗方法。越来越多的证据表明它们也具有协同作用,并且正在临床环境中广泛研究联合治疗。此外,越来越多的证据表明,纳米技术支持的疗法可以增强放射疗法和免疫疗法,进而改善这两种疗法。这是一个令人兴奋的跨学科科学新领域,具有产生重大临床影响的巨大潜力。该领域的一些方法已经进入临床阶段。在这篇综述中,我们将讨论放射疗法、免疫疗法和纳米医学之间相互作用的最新进展。我们计划审查将这三个领域结合起来进行癌症治疗的多种方法。
更新日期:2020-12-16
down
wechat
bug